CN1545514A - β型晶体无水氨曲南的生产方法 - Google Patents

β型晶体无水氨曲南的生产方法 Download PDF

Info

Publication number
CN1545514A
CN1545514A CNA028163427A CN02816342A CN1545514A CN 1545514 A CN1545514 A CN 1545514A CN A028163427 A CNA028163427 A CN A028163427A CN 02816342 A CN02816342 A CN 02816342A CN 1545514 A CN1545514 A CN 1545514A
Authority
CN
China
Prior art keywords
aztreonam
solution
amino
type
anhydrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028163427A
Other languages
English (en)
Chinese (zh)
Inventor
摩西・塔卡西纳・查恩迪兰
摩西·塔卡西纳·查恩迪兰
拉亚纳・叶南
萨塔纳拉亚纳·叶南
・拉梅什
丹德拉·拉梅什
玛拉・桑德拉姆・米纳科什
西瓦库玛拉·桑德拉姆·米纳科什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurobindo Pharma Ltd
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Publication of CN1545514A publication Critical patent/CN1545514A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CNA028163427A 2001-08-27 2002-08-21 β型晶体无水氨曲南的生产方法 Pending CN1545514A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN700/MAS/2001 2001-08-27
IN700CH2001 2001-08-27

Publications (1)

Publication Number Publication Date
CN1545514A true CN1545514A (zh) 2004-11-10

Family

ID=11097009

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028163427A Pending CN1545514A (zh) 2001-08-27 2002-08-21 β型晶体无水氨曲南的生产方法

Country Status (2)

Country Link
CN (1) CN1545514A (fr)
WO (1) WO2003018578A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101412715B (zh) * 2008-12-16 2010-04-14 海南百那医药发展有限公司 一种氨曲南化合物及其制法
CN101579336B (zh) * 2009-07-07 2010-06-23 重庆市庆余堂制药有限公司 一种注射用氨曲南及其生产方法
CN101830895A (zh) * 2010-04-16 2010-09-15 海南新中正制药有限公司 氨曲南无水晶型化合物及其制备方法
CN102351855A (zh) * 2011-08-12 2012-02-15 山西仟源制药股份有限公司 β晶型氨曲南无菌原料药的生产方法
CN103232449A (zh) * 2013-05-08 2013-08-07 四川省惠达药业有限公司 一种氨曲南化合物、其制备方法及其药物组合物
CN116178363A (zh) * 2023-03-06 2023-05-30 广安凯特制药有限公司 一种制备β晶型氨曲南的方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100687001B1 (ko) 2002-08-05 2007-02-27 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 아즈트레오남의 제법
WO2004103999A1 (fr) * 2003-05-15 2004-12-02 TEVA Gyógyszergyár Részvénytársaság Polymorphe ? de aztreonam avec tres faible contenu en solvant residuel
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
AU2004256124B2 (en) 2003-07-02 2011-04-28 Corus Pharma, Inc. Aztreonam L-lysine and methods for the preparation thereof
ES2321336T3 (es) 2005-05-09 2009-06-04 Sicor Inc. Procedimiento para la fabricacion de aztreonam.
CN113876722B (zh) * 2021-11-04 2022-12-02 海南皇隆制药股份有限公司 注射用氨曲南及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
CA1181075A (fr) * 1981-07-13 1985-01-15 David M. Floyd FORME CRISTALLISEE ANHYDRE DE L'ACIDE[3-S-[.alpha. (Z),4.beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL]AMINO ]-4-METHYL-2-OXO-1-AZETIDINESULFONIQUE
US4826973A (en) * 1984-07-20 1989-05-02 E. R. Squibb & Sons, Inc. Delta form of aztreonam and preparation thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101412715B (zh) * 2008-12-16 2010-04-14 海南百那医药发展有限公司 一种氨曲南化合物及其制法
CN101579336B (zh) * 2009-07-07 2010-06-23 重庆市庆余堂制药有限公司 一种注射用氨曲南及其生产方法
CN101830895A (zh) * 2010-04-16 2010-09-15 海南新中正制药有限公司 氨曲南无水晶型化合物及其制备方法
CN102351855A (zh) * 2011-08-12 2012-02-15 山西仟源制药股份有限公司 β晶型氨曲南无菌原料药的生产方法
CN103232449A (zh) * 2013-05-08 2013-08-07 四川省惠达药业有限公司 一种氨曲南化合物、其制备方法及其药物组合物
CN116178363A (zh) * 2023-03-06 2023-05-30 广安凯特制药有限公司 一种制备β晶型氨曲南的方法

Also Published As

Publication number Publication date
WO2003018578A1 (fr) 2003-03-06

Similar Documents

Publication Publication Date Title
CN1545514A (zh) β型晶体无水氨曲南的生产方法
EP0579681B1 (fr) Monohydrate d'hydrochlorure de tiagabine cristalline, sa preparation et son utilisation
CA1181075A (fr) FORME CRISTALLISEE ANHYDRE DE L'ACIDE[3-S-[.alpha. (Z),4.beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL]AMINO ]-4-METHYL-2-OXO-1-AZETIDINESULFONIQUE
LU86540A1 (fr) Sels de cephalosporine et compositions injectables
JPH10511377A (ja) セフォタキシムの製造
JP2024500665A (ja) ２－ヒドロキシ－５－［２－（４－（トリフルオロメチルフェニル）エチルアミノ）］安息香酸結晶形およびこの製造方法
CN1175952A (zh) 克拉维酸盐及其制备方法
US6465437B1 (en) Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
CN1090636C (zh) 棒酸盐的制备
JPH01502660A (ja) Ｎ―１置換スルホニルアミノカルボニル、ｃ―４置換モノバクタム類
EP0099297B1 (fr) Nouveaux dérivés des céphalosporines, leur procédé de préparation et médicaments antibiotiques contenant lesdits dérivés
FR2952M (fr)
NZ227842A (en) Crystalline 2.5-hydrate form of a beta-lactam
US5302588A (en) Crystalline (5R,6S)-2-carbamoyloxymethyl-6-[(1R)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation
KR0137211B1 (ko) 세팔로스포린유도체의 결정성 2염산염 및 그 제조법
KR20040069957A (ko) 메실산 나파모스타트의 결정 다형 및 그 제조방법
KR100509737B1 (ko) 7-아미노세팔로스포란산의 결정화 방법
CN1295234C (zh) 一种头孢呋辛酯非对映异构体的分离方法
KR100917593B1 (ko) 덱시부프로펜염의 제조방법
NZ310542A (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin selected from its polymorph, its pseodomorphs and the monohydrate, preparation and pharmaceutical compositions thereof
TW202227387A (zh) 單水合曲前列環素晶體及其製備方法
CN118615461A (zh) 阴离子开环葫芦脲和别嘌醇的包合物及其制备方法和应用
JPS63141985A (ja) 改良された薬物動力学的特性を有する新規セファロスポリン誘導体、その製造方法および薬組成物
JPH0673085A (ja) デカプラニン塩溶液および結晶デカプラニン塩ならびにそれらの調製方法
JP2010285355A (ja) β−ラクタム化合物の安定形結晶の製法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication